Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Wegovy offers a prescription injectable medication approved by the US Food and Drug Administration for weight loss management in adults and adolescents
Important: Retatrutide is investigational and unlicensed in the UK
Because this peptide works on three key hormone receptors, researchers expect improved long-term metabolic adaptation and lower risk of plateauing weight loss progress during maintenance dose phases
Retatrutide is an investigational once-weekly injectable peptide that simultaneously activates GLP-1, GIP, and glucagon receptors, but it is not yet approved by the MHRA or EMA and remains experimental
US$ 27.39
US$ 20.89
US$ 23.89
US$ 23.21
US$ 25.13
US$ 29.57
US$ 21.92
US$ 28.56
US$ 28.91
